948
Views
45
CrossRef citations to date
0
Altmetric
Original

Cyclooxygenase-2 inhibitor delays fracture healing in rats

, , , , , , , & show all
Pages 470-472 | Received 07 Apr 2004, Accepted 10 Dec 2004, Published online: 08 Jul 2009

  • Altman R D, Latta L L, Keer R, Renfree K, Hornicek F J, Banovac K. Effect of nonsteroidal antiinflammatory drugs on fracture healing: a laboratory study in rats. J Orthop Trauma 1995; 9(5)392–400
  • An Y H, Friedman R J, Draughn R A. Animal models of bone fracture or osteotomy. Animal models in Orthopaedic research, Y H An, R J Friedman. CRC Press, Boca Raton 1999; 197–217
  • Bonnarens F, Einhorn T A. Production of a standard closed fracture in laboratory animal bone. J Orthop Res 1984; 2(1)97–101
  • Brown K M, Saunders M M, Kirsch T, Donahue H J, Reid J S. Effect of COX-2-specific inhibition on fracture-healing in the rat femur. J Bone Joint Surg (Am) 2004; 86(1)116–23
  • Einhorn T A, Majeska R J, Rush E B, Levine P M, Horowitz MC. The expression of cytokine activity by fracture callus. J Bone Miner Res 1995; 10(8)1272–81
  • Elves M W, Bayley I, Roylance P J. The effect of indomethacin upon experimental fractures in the rat. Acta Orthop Scand 1982; 53(1)35–41
  • Endo K, Sairyo K, Komatsubara S, Sasa T, Egawa H, Yonekura D, Adachki K, Ogawa T, Murakami R, Yasui N. Cyclooxygenase-2 inhibitor inhibits the fracture healing. J Physiol Anthropol Appl Human Sci 2002; 21(5)235–8
  • Gerstenfeld L C, Cho T J, Kon T, Aizawa T, Cruceta J, Graves B D, Einhorn T A. Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs 2001; 169(3)285–94
  • Gerstenfeld L C, Thiede M, Seibert K, Mielke C, Phippard D, Svagr B, Cullinane D, Einhorn T A. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal antiinflammatory drugs. J Orthop Res 2003; 21(4)670–5
  • Jingushi S, Heydemann A, Kana S K, Macey L R, Bolander M E. Acidic fibroblast growth factor (aFGF) injection stimulates cartilage enlargement and inhibits cartilage gene expression in rat fracture healing. J Orthop Res 1990; 8(3)364–71
  • Koide M, Murase Y, Yamato K, Noguchi T, Okahashi N, Nishihara T. Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2. Biochem Biophys Res Commun 1999; 259(1)97–102
  • Nakamura T, Kurokawa T, Orimo H. Increased mechanical strength of the vitamin D-replete rat femur by the treatment with a large dose of 24R,25(OH)2D3. Bone 1989; 10(2)117–23
  • Simon A M, Manigrasso M B, O'Connor J P. Cyclooxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002; 17(6)963–76
  • Warner T D, Giuliano F, Vojnovic I, Bukasa A, Mitchell J A, Vane J R. Nonsteroid drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proc Natl Acad Sci 1999; 96(13)7563–8
  • Zhang X, Schwarz E M, Young D A, Puzas J E, Rosier R N, O'Keefe R J. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002; 109(11)1405–15

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.